HUP0200995A3 - Taxane formulations having improved solubility - Google Patents

Taxane formulations having improved solubility

Info

Publication number
HUP0200995A3
HUP0200995A3 HU0200995A HUP0200995A HUP0200995A3 HU P0200995 A3 HUP0200995 A3 HU P0200995A3 HU 0200995 A HU0200995 A HU 0200995A HU P0200995 A HUP0200995 A HU P0200995A HU P0200995 A3 HUP0200995 A3 HU P0200995A3
Authority
HU
Hungary
Prior art keywords
improved solubility
taxane formulations
taxane
formulations
solubility
Prior art date
Application number
HU0200995A
Other languages
English (en)
Original Assignee
Univ Florida State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State Res Found filed Critical Univ Florida State Res Found
Publication of HUP0200995A2 publication Critical patent/HUP0200995A2/hu
Publication of HUP0200995A3 publication Critical patent/HUP0200995A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
HU0200995A 2000-02-02 2001-02-02 Taxane formulations having improved solubility HUP0200995A3 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US17967100P 2000-02-02 2000-02-02
US17968400P 2000-02-02 2000-02-02
US17979300P 2000-02-02 2000-02-02
US17978200P 2000-02-02 2000-02-02
US17967400P 2000-02-02 2000-02-02
US17967000P 2000-02-02 2000-02-02
US17966900P 2000-02-02 2000-02-02
US17967200P 2000-02-02 2000-02-02

Publications (2)

Publication Number Publication Date
HUP0200995A2 HUP0200995A2 (hu) 2002-07-29
HUP0200995A3 true HUP0200995A3 (en) 2005-02-28

Family

ID=27575082

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200995A HUP0200995A3 (en) 2000-02-02 2001-02-02 Taxane formulations having improved solubility

Country Status (9)

Country Link
EP (1) EP1175414A1 (hu)
KR (1) KR20010111580A (hu)
AU (1) AU3481001A (hu)
BR (1) BR0104358A (hu)
HU (1) HUP0200995A3 (hu)
IL (1) IL145635A0 (hu)
NO (1) NO20014752L (hu)
NZ (1) NZ514073A (hu)
WO (1) WO2001057013A1 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2368534A1 (en) 2000-02-02 2001-08-09 Florida State University Research Foundation, Inc. C7 heterosubstituted acetate taxanes as antitumor agents
CZ20013520A3 (cs) 2000-02-02 2002-03-13 Florida State University Research Foundation, Inc. C10 - Karbamoyloxy substituované taxany jako protinádorová činidla
IL145636A0 (en) 2000-02-02 2002-06-30 Univ Florida State Res Found C10 carbonate substituted taxanes as antitumor agents
NZ514406A (en) 2000-02-02 2005-01-28 Univ Florida State Res Found C10 heterosubstituted acetate taxanes as antitumor agents
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
MXPA01009906A (es) 2000-02-02 2003-07-28 Univ Florida State Res Found Taxanos sustituidos con carbonato en c7 como agentes.
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
CA2354486A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C7 ester substituted taxanes
CA2354478A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 carbonate substituted taxanes
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
MXPA05001390A (es) 2002-08-02 2005-07-29 Immunogen Inc Agentes citotoxicos que contienen taxanos potentes novedosos y su uso terapeutico.
HN2005000054A (es) 2004-02-13 2009-02-18 Florida State University Foundation Inc Taxanos sustituidos con esteres de ciclopentilo en c10
US7160919B2 (en) 2004-03-05 2007-01-09 Florida State University Research Foundation, Inc. C7 lactyloxy-substituted taxanes
WO2009145981A1 (en) * 2008-03-31 2009-12-03 Florida State University Research Foundation, Inc. C(10) ethyl ester and c(10) cyclopropyl ester substituted taxanes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
MX9307777A (es) * 1992-12-15 1994-07-29 Upjohn Co 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
JPH09504033A (ja) * 1993-10-20 1997-04-22 エンゾン,インコーポレーテッド 2’−及び/又は7−置換タキソイド類
WO1996013495A1 (en) * 1994-10-28 1996-05-09 The Research Foundation Of State University Of New York Taxoid derivatives, their preparation and their use as antitumor agents
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US5801191A (en) * 1995-06-01 1998-09-01 Biophysica Foundation Taxoids
WO1998002426A1 (fr) * 1996-07-15 1998-01-22 Kabushiki Kaisha Yakult Honsha Derives de taxane et medicaments les contenant
JPH1192468A (ja) * 1997-09-17 1999-04-06 Yakult Honsha Co Ltd 新規なタキサン誘導体
US6268381B1 (en) * 1997-12-19 2001-07-31 Kabushiki Kaisha Yakult Honsha Taxane derivatives
JP2003026673A (ja) * 1999-03-05 2003-01-29 Asahi Kasei Corp 骨形成促進剤

Also Published As

Publication number Publication date
IL145635A0 (en) 2002-06-30
KR20010111580A (ko) 2001-12-19
EP1175414A1 (en) 2002-01-30
HUP0200995A2 (hu) 2002-07-29
NO20014752L (no) 2001-11-27
NO20014752D0 (no) 2001-10-01
WO2001057013A1 (en) 2001-08-09
NZ514073A (en) 2004-02-27
AU3481001A (en) 2001-08-14
BR0104358A (pt) 2002-01-02

Similar Documents

Publication Publication Date Title
HUP0301413A3 (en) Vaccine compositions
HUP0302117A3 (en) Vaccine composition
GB0001621D0 (en) Pharmaceutical compositions
GB0020089D0 (en) Vaccine Composition
AU6219601A (en) Pharmaceutical compositions
PL350075A1 (en) Taxane formulations having improved solubility
GB0009584D0 (en) Pharmaceutical compositions
GB0019232D0 (en) Antiperspirant formulations
EP1320385A4 (en) COMBINATION COMPOSITIONS
AU8576801A (en) Pharmaceutical compositions
HUP0200995A3 (en) Taxane formulations having improved solubility
GB0015490D0 (en) Novel formulations
AU1390002A (en) Pharmaceutical compositions
GB0019651D0 (en) Compositions
GB0008485D0 (en) Pharmaceutical compositions
GB0019230D0 (en) Antiperspirant formulations
GB0009613D0 (en) Pharmaceutical compositions
GB0009607D0 (en) Medical compositions
HK1061978A1 (en) Lipid peroxide-lowering compositions
HUP0600589A2 (en) Adjuvant combination formulations
GB0004518D0 (en) Compositions
HK1047933A1 (zh) 具有改善的溶解度的紫杉烷製劑
AU8254101A (en) Medicinal compositions
GB0004522D0 (en) Compositions
GB0022027D0 (en) Disfectant formulations